Wen Zhang

Dr. Wen Zhang


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 October 2025 in Neurotherapeutics
Verified
Journal Article
Open access
JLJielian Luo
Jielian Luo
CZChen Zhang
Chen Zhang
RDRou Deng
Rou Deng
LLLiang Liu
Liang Liu
CHChenming He
Chenming He
BFBang-jiang Fang
Bang-jiang Fang
Prolonged mechanical ventilation (PMV) is associated with increased morbidity and mortality among critically ill patients with ischemic stroke, yet data on its risk factors remain limited. This study aimed to identify independent predictors of PMV in this population. Ischemic stroke patients were identified from the Medical Information Mart for Intensive Care IV database. PMV was defined as mechanical ventilation lasting more than 14 days. Multivariable logistic regression was used to identify factors associated with PMV. Model performance was assessed using receiver operating characteristic curves, calibration plots, and decision curve analysis. A total of 756 ischemic stroke patients were included, of whom 111 (14.7 ​%) required PMV. In-hospital and one-year mortality rates in the PMV group were 27.0 ​% and 45.9 ​% respectively. Independent risk factors for PMV included BMI ≥33 ​kg/m2 (OR 1.82, 95 ​% CI 1.10-3.02), COPD (OR 2.02, 95 ​% CI 1.25-3.24), pH ​≥ ​7.45 (OR 1.79, 95 ​% CI 1.12-2.86), respiratory rate ≥20 min-1 (OR 2.39, 95 ​% CI 1.47-3.88), sepsis onset before D14 (OR 8.48, 95 ​% CI 1.75-41.06), tracheostomy (OR 7.38, 95 ​% CI 4.38-12.44), vasopressor (OR 2.19, 95 ​% CI 1.26-3.79) and pneumonia onset before D14 (OR 1.68, 95 ​% CI 1.01-2.79). These variables were incorporated into a nomogram, which demonstrated good discrimination (AUC 0.86, 95 ​% CI 0.83-0.89) and calibration (Hosmer-Lemeshow P ​= ​0.149). In conclusion, PMV in critically ill ischemic stroke patients is associated with COPD, sepsis, obesity, alkalosis, increased respiratory rate, tracheostomy, vasopressor use, and pneumonia. The predictive model incorporating these factors showed good diagnostic performance and may aid early risk stratification and management.

9 June 2023 in Medicine
Verified
Journal Article
Open access
CCCaiyu Chen
Caiyu Chen
XWXinxin Wu
Xinxin Wu
WZWen Zhang
Wen Zhang
YPYuting Pu
Yuting Pu
XXXiangru Xu
Xiangru Xu
BFBang-jiang Fang
Bang-jiang Fang
Sepsis has emerged as a major global public health concern due to its elevated mortality and high cost of care. This study aimed to evaluate the risk factors associated with the mortality of sepsis patients in the Intensive Care Unit (ICU), and to intervene in the early stages of sepsis in order to improve patient outcomes and reduce mortality. From January 1st, 2021 to December 31st, 2021, Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Huashan Hospital Affiliated to Fudan University, and The Seventh People’s Hospital Affiliated to Shanghai University of Traditional Chinese Medicine were designated as sentinel hospitals, and sepsis patients in their respective ICU and Emergency ICU were selected as research subjects, and divided into survivors and non-survivors according to their discharge outcomes. The mortality risk of sepsis patients was subsequently analyzed by logistic regression. A total of 176 patients with sepsis were included, of which 130 (73.9%) were survivors and 46 (26.1%) were non-survivors. Factors identified as having an impact on death among sepsis patients included female [Odds Ratio (OR) = 5.135, 95% confidence interval (CI): 1.709, 15.427, P = .004)], cardiovascular disease (OR = 6.272, 95% CI: 1.828, 21.518, P = .004), cerebrovascular disease (OR = 3.133, 95% CI: 1.093, 8.981, P = .034), pulmonary infections (OR = 6.700, 95% CI: 1.744, 25.748, P = .006), use of vasopressors (OR = 34.085, 95% CI: 10.452, 111.155, P < .001), WBC < 3.5 × 109/L (OR = 9.752, 95% CI: 1.386, 68.620, P = .022), ALT < 7 U/L (OR = 7.672, 95% CI: 1.263, 46.594, P = .027), ALT > 40 U/L (OR = 3.343, 95% CI: 1.097, 10.185, P = .034). Gender, cardiovascular disease, cerebrovascular disease, pulmonary infections, the use of vasopressors, WBC, and ALT are important factors in evaluating the prognostic outcome of sepsis patients in the ICU. This suggests that medical professionals should recognize them expeditiously and implement aggressive treatment tactics to diminish the mortality rate and improve outcomes.

18 December 2024 in Frontiers in Pharmacology
Verified
Journal Article
Open access
PDF file
RDRou Deng
Rou Deng
XCXiayu Cui
Xiayu Cui
RZRunze Zhang
Runze Zhang
CLChangya Liu
Changya Liu
JLJielian Luo
Jielian Luo
BFBang-jiang Fang
Bang-jiang Fang
Sepsis is a systemic inflammatory response initiated by an infection, which can lead to multi-organ dysfunction. The pathophysiology of sepsis is complex, and treatment options are limited. Traditional antibiotic therapies have shown limitations, such as promoting the emergence of antibiotic-resistant bacteria and disrupting the natural microbiota. Consequently, there is a pressing need to explore diverse therapeutic approaches for sepsis management. Extracellular vesicles, which play a crucial role in cell-to-cell communication, are released by various cell types throughout the body and possess a membrane structure composed of a lipid bilayer. MicroRNAs may be encapsulated within these structures and can be selectively delivered to target recipient cells through the activation of cell surface receptors or via endocytosis and fusion, thereby modulating the biological functions of target cells. The article examines the pathological alterations that happen as sepsis progresses and the biological control of extracellular vesicles and microRNAs in sepsis. This review focuses on the role of extracellular vesicles and their microRNAs on controlling the inflammatory response, macrophage polarization, programmed cell death, endothelial dysfunction, and microcirculatory changes in sepsis. Furthermore, the obstacles encountered by this novel therapy are also examined.

19 June 2025 in Frontiers in Microbiology
Verified
Journal Article
Open access
PDF file
RZRunze Zhang
Runze Zhang
CHChenxing Huo
Chenxing Huo
CHChenming He
Chenming He
JLJielian Luo
Jielian Luo
YSYunan Shan
Yunan Shan
BFBang-jiang Fang
Bang-jiang Fang
Background: Sepsis is a life-threatening condition characterized by organ dysfunction resulting from a dysregulated host response to infection, with pathological mechanisms closely linked to imbalances in the intestinal flora. While the gut microbiota influences sepsis progression through metabolic and immune regulation, systematic analyses of research trends remain limited. This bibliometric study comprehensively evaluates the sepsis and gut microbiota field from 2014 to 2024.Methods: We analyzed 944 English-language articles from the Web of Science (WOS) Core Collection using CiteSpace, VOSviewer, and other software tools. The bibliometric assessments included analysis of publication trends, collaborative networks, geographic distributions, journal impact, and keyword clustering.Results: A total of 944 publications included contributions from 5,901 authors across 69 countries. These works were published in 405 journals, and cited a total of 45,932 references. The focus of research has transitioned from early topics such as “necrotizing enterocolitis” and “premature infants” to more recent interests on “short-chain fatty acids” (SCFAs) and “Candida albicans.” Futhermore, emerging topics include “sepsis-associated encephalopathy,” with microbiology and critical care medicine identified as interdisciplinary core fields.Conclusion: The therapeutic potential of the gut microbiota in sepsis is increasingly recognized. Future research should prioritize microbial-targeted therapies, immune-barrier-metabolic network regulation, and integrated traditional Chinese–Western medicine approaches.

5 August 2025 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
RDRou Deng
Rou Deng
YHYingying Hu
Yingying Hu
JLJielian Luo
Jielian Luo
XCXiayu Cui
Xiayu Cui
CHChenxing Huo
Chenxing Huo
BFBang-jiang Fang
Bang-jiang Fang

1 March 2026 in International Journal of Chronic Obstructive Pulmonary Disease
Verified
Journal Article
Open access
PDF file
JZJirong Zhang
Jirong Zhang
NSNing Sun
Ning Sun
CHChenming He
Chenming He
LLLiang Liu
Liang Liu
CWChuanqi Wan
Chuanqi Wan
BFBang-jiang Fang
Bang-jiang Fang
Purpose: To map the research landscape and synthesize randomized evidence on cognitive interventions for adults with chronic lung disease (CLD). Methods: This two-stage study involved: (i) bibliometric mapping of Web of Science Core Collection (WOSCC) (Jan 2005–May 2025) to evaluate output, collaboration, and thematic trends via VOSviewer, CiteSpace, and Bibliometrix; and (ii) narrative synthesis of Randomized Controlled Trials (RCTs) in adults (≥ 18 y) with chronic lung diseases and validated cognitive outcomes, identified from WOSCC, Scopus, and PubMed (to May 1, 2025). Screening, data extraction, and RoB 2 assessment were conducted in duplicate. Results: Bibliometric mapping (2005– 2025) of 3,474 publications showed sustained growth, broad international collaboration, and a shift from epidemiology to mechanisms and patient-centered outcomes. Fifteen RCTs, mostly in stable Chronic Obstructive Pulmonary Disease (COPD), assessed inspiratory-muscle/breathing training, aerobic-resistance or dance exercise, exercise with behavioral/educational components, multimodal cognitive-lifestyle programs, and pharmacological/nutritional or acute physiological therapies Montreal Cognitive Assessment (MoCA) and Mini-Mental State Examination (MMSE) were the most common cognitive measures, alongside executive-function tests. Methodological quality was generally moderate. Conclusion: Bibliometrics and randomized-trial synthesis reveal a rapidly growing, globally connected CLD-cognition field moving from epidemiology toward mechanistic and patient-centered research. Multimodal PR, especially exercise and inspiratory-muscle training, shows neurotherapeutic promise, but substantial gaps persist in Low and Middle Income Countries (LMICs) and non-COPD populations.